Characterizing the Role of Arachidonic Acid-Derived Eicosanoids in Breast Cancer
CSEF · 2010 Pharmacology (Senior Division Only)
Overview
Objectives/Goals This project was done in an attempt to answer two questions: Were these inflammatory molecules, and thus the inflammatory response, also associated with breast adenocarcinomas? Eicosanoids can be produced via diverse metabolic pathways. However, only a few have significant output of a variety of eicosanoids -- and one, the arachidonic acid pathway, is a particularly appealing pathway because it involves the inducible (generally inactive) enzyme cycloxygenase-2 (COX-2). Was the notorious arachidonic acid pathway responsible for any elevated eicosanoid output? Methods/Materials The procedure I devised to determine the relationship between arachidonic acid (AA) and eicosanoid production can be split up into three major subprocedures. 1) A cancerous (MCF7) and a noncancerous (MCF10a) cell line were cultured and tested for viability at various concentrations of AA. 2) The two cell lines were given arachidonic acid treatments at 200 and 250 micromolar concentrations, and the pellet and media eicosanoids were collected. 3) Eicosanoid production was characterized and quantified through HPLC analysis. Results The MCF10a cell line exhibited a strong dose-response relationship. The MCF7 cell line did not--its eicosanoid production without the input of any arachidonic acid was already very high. This dose-response relationship in the MCF10a cell line was reflected in both cellular eicosanoid levels--measured from the pellet--and secreted eicosanoid levels--measured from the media. Conclusions/Discussion That I was able to isolate such a significant amount of eicosanoids from the MCF7 cell line is both anticipated and explanatory. It tells us that inflammation plays a key role in the maintainable of growth in this particular adenocarcinoma. Not only do the cells exhibit the lack of density-dependent regulation characteristic of the majority of cancer cells, these in particular bolster their proliferation capabilities through the secretion of these inflammatory eicosanoids.
Summary statement
My project was to compare the effects of a particular type of inflammation on normal breast endothelial (MCF10a) and breast adenocarcinoma (MCF7) cell lines, and thereby determine whether cancer cells use it to proliferate.
Help received
Participant in research internship sweepstakes (UTEP/CRP), used lab equiptment at the Das Research Group at University of Texas, El Paso. They taught me to use many of the lab equiptment that I would need to conduct my research.
Competition history
- CSEF 2010
Resources
Related projects
ISEF · 2016
The Effects of Nonsteroidal Anti-Inflammatory Agents on Cancer Cells
CSEF · 2010
Soy: Carcinogen or Prevention?
CSEF · 2009
Mechanisms of Survival Against a Fatty Acid Synthase Inhibitor in Multidrug Resistant Ovarian Cancer
ISEF · 2020
Linking Diet and Cancer: Arachidonic Acid Augments Canonical Wnt Signaling to Enhance Stemness
CSEF · 2011
Studying the Link between Gastroesophageal Reflux Disease and Adenocarcinoma Esophageal Cancer in Humans
CSEF · 2017
Cellular Factors Involved in the Progression of DCIS to Invasive Breast Cancer Using Computer Based Simulation
CSEF · 2011
Fortifying the Cell's Defenses: The Effects of Fish Oil on Cell Membrane Strength
ISEF · 2015
Search for New Ways to Improve Immune Response against Cancer: Modulation of FASL (CD95L) by Lipid Mediators on Lymphocytes
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects